CHU de Grenoble Alpes

Grenoble 38043 Cedex 9

0 studies enrolling now · 3 studies all time

What they study most

COVID-19, Parkinson Disease

Studies at this site

• MP1032 Treatment in Patients With Moderate to Severe COVID-19 — Completed
• Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations — Stopped early
• Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease — Stopped early